139 related articles for article (PubMed ID: 25813475)
1. LRIG1 is a prognostic biomarker in non-small cell lung cancer.
Kvarnbrink S; Karlsson T; Edlund K; Botling J; Lindquist D; Jirström K; Micke P; Henriksson R; Johansson M; Hedman H
Acta Oncol; 2015; 54(8):1113-9. PubMed ID: 25813475
[TBL] [Abstract][Full Text] [Related]
2. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
Karlsson T; Kvarnbrink S; Holmlund C; Botling J; Micke P; Henriksson R; Johansson M; Hedman H
Lung Cancer; 2018 Nov; 125():174-184. PubMed ID: 30429017
[TBL] [Abstract][Full Text] [Related]
3. LRIG and cancer prognosis.
Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
[TBL] [Abstract][Full Text] [Related]
4. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
5. Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer.
An Y; Zhao Z; Ou P; Wang G
Medicine (Baltimore); 2015 Nov; 94(47):e2081. PubMed ID: 26632716
[TBL] [Abstract][Full Text] [Related]
6. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
[TBL] [Abstract][Full Text] [Related]
7. Leucine-rich repeats and immunoglobulin-like domains protein 1 and fascin actin-bundling protein 1 expression in nonsmall cell lung cancer.
Zhang J; Wang X; Zhang Y; Wu J; Zhou N
J Cancer Res Ther; 2016 Dec; 12(Supplement):C248-C251. PubMed ID: 28230028
[TBL] [Abstract][Full Text] [Related]
8. High-level expression of Hsp90β is associated with poor survival in resectable non-small-cell lung cancer patients.
Kim SH; Ji JH; Park KT; Lee JH; Kang KW; Park JH; Hwang SW; Lee EH; Cho YJ; Jeong YY; Kim HC; Lee JD; Jang I; Lee JS; Lee HW; Lee GW
Histopathology; 2015 Oct; 67(4):509-19. PubMed ID: 25704653
[TBL] [Abstract][Full Text] [Related]
9. Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.
Ranhem C; Lillsunde Larsson G; Hedman H; Lindquist D; Karlsson MG; Hellström AC; Östensson E; Sorbe B; Hellman K; Andersson S
PLoS One; 2017; 12(8):e0183816. PubMed ID: 28841699
[TBL] [Abstract][Full Text] [Related]
10. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of fibroblast growth factor 1 in non-small cell lung cancer.
Li J; Wei Z; Li H; Dang Q; Zhang Z; Wang L; Gao W; Zhang P; Yang D; Liu J; Sun Y; Gao W
Hum Pathol; 2015 Dec; 46(12):1821-8. PubMed ID: 26391572
[TBL] [Abstract][Full Text] [Related]
12. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.
Ghasimi S; Haapasalo H; Eray M; Korhonen K; Brännström T; Hedman H; Andersson U
J Neurooncol; 2012 Jul; 108(3):435-41. PubMed ID: 22484910
[TBL] [Abstract][Full Text] [Related]
14. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer.
Cao X; Tang Z; Huang F; Jin Q; Zhou X; Shi J
Oncotarget; 2017 Feb; 8(8):12812-12819. PubMed ID: 28086212
[TBL] [Abstract][Full Text] [Related]
15. In vivo analysis of Lrig genes reveals redundant and independent functions in the inner ear.
Del Rio T; Nishitani AM; Yu WM; Goodrich LV
PLoS Genet; 2013; 9(9):e1003824. PubMed ID: 24086156
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.
Cooper WA; Tran T; Vilain RE; Madore J; Selinger CI; Kohonen-Corish M; Yip P; Yu B; O'Toole SA; McCaughan BC; Yearley JH; Horvath LG; Kao S; Boyer M; Scolyer RA
Lung Cancer; 2015 Aug; 89(2):181-8. PubMed ID: 26024796
[TBL] [Abstract][Full Text] [Related]
17. Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma.
Vigouroux C; Casse JM; Battaglia-Hsu SF; Brochin L; Luc A; Paris C; Lacomme S; Gueant JL; Vignaud JM; Gauchotte G
Lung Cancer; 2015 Aug; 89(2):189-96. PubMed ID: 26013954
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
19. Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer.
Liang JZ; Li YH; Zhang Y; Wu QN; Wu QL
Int J Clin Exp Pathol; 2015; 8(3):2937-45. PubMed ID: 26045802
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.
Sato T; Soejima K; Arai E; Hamamoto J; Yasuda H; Arai D; Ishioka K; Ohgino K; Naoki K; Kohno T; Tsuta K; Watanabe S; Kanai Y; Betsuyaku T
Oncol Rep; 2015 Sep; 34(3):1137-45. PubMed ID: 26134684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
